Concepts (249)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Rotavirus | 48 | 2013 | 363 | 3.380 |
Why?
|
| Rotavirus Infections | 17 | 2013 | 278 | 1.200 |
Why?
|
| RNA, Viral | 24 | 2011 | 511 | 1.160 |
Why?
|
| Antigens, Viral | 16 | 2007 | 392 | 0.980 |
Why?
|
| Reoviridae | 23 | 1994 | 34 | 0.950 |
Why?
|
| Genes, Viral | 20 | 1998 | 156 | 0.860 |
Why?
|
| Capsid | 13 | 2001 | 90 | 0.830 |
Why?
|
| Virus Replication | 18 | 2011 | 593 | 0.740 |
Why?
|
| Capsid Proteins | 13 | 2013 | 143 | 0.720 |
Why?
|
| Bacteriophages | 4 | 2021 | 86 | 0.580 |
Why?
|
| Genome, Viral | 5 | 2017 | 153 | 0.540 |
Why?
|
| Recombination, Genetic | 19 | 2002 | 418 | 0.520 |
Why?
|
| Extraintestinal Pathogenic Escherichia coli | 3 | 2021 | 19 | 0.440 |
Why?
|
| Mutation | 22 | 2011 | 5953 | 0.400 |
Why?
|
| Bluetongue virus | 6 | 1989 | 9 | 0.350 |
Why?
|
| Reassortant Viruses | 5 | 2011 | 28 | 0.320 |
Why?
|
| Microbial Viability | 3 | 2021 | 42 | 0.310 |
Why?
|
| Temperature | 20 | 2011 | 289 | 0.310 |
Why?
|
| Viral Nonstructural Proteins | 5 | 2003 | 139 | 0.280 |
Why?
|
| Viremia | 2 | 2007 | 129 | 0.270 |
Why?
|
| Suppression, Genetic | 6 | 1998 | 41 | 0.270 |
Why?
|
| Phage Therapy | 3 | 2021 | 39 | 0.250 |
Why?
|
| Polysaccharides | 2 | 2021 | 140 | 0.250 |
Why?
|
| Chromosome Mapping | 6 | 2011 | 1054 | 0.240 |
Why?
|
| Animals | 48 | 2021 | 33234 | 0.240 |
Why?
|
| Escherichia coli | 3 | 2021 | 963 | 0.220 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 3 | 2021 | 149 | 0.190 |
Why?
|
| Promoter Regions, Genetic | 2 | 1996 | 1206 | 0.190 |
Why?
|
| Intestines | 4 | 2003 | 578 | 0.190 |
Why?
|
| Gastroenteritis | 1 | 2004 | 307 | 0.180 |
Why?
|
| Cell Line | 14 | 2002 | 2567 | 0.180 |
Why?
|
| Lymph Nodes | 1 | 2003 | 374 | 0.180 |
Why?
|
| Blood | 2 | 2021 | 99 | 0.180 |
Why?
|
| Viral Tail Proteins | 1 | 2021 | 6 | 0.170 |
Why?
|
| Viral Proteins | 8 | 1994 | 336 | 0.170 |
Why?
|
| Heparan Sulfate Proteoglycans | 1 | 2021 | 15 | 0.170 |
Why?
|
| Microbial Interactions | 1 | 2021 | 15 | 0.170 |
Why?
|
| Baculoviridae | 3 | 1996 | 41 | 0.160 |
Why?
|
| Prosthesis-Related Infections | 1 | 2021 | 183 | 0.150 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 2520 | 0.150 |
Why?
|
| Gastrointestinal Tract | 1 | 2021 | 218 | 0.150 |
Why?
|
| Liver | 3 | 2004 | 1765 | 0.150 |
Why?
|
| Molecular Sequence Data | 6 | 2011 | 3590 | 0.150 |
Why?
|
| Coliphages | 1 | 2018 | 4 | 0.140 |
Why?
|
| Bacteriolysis | 1 | 2018 | 6 | 0.140 |
Why?
|
| Orthoreovirus | 1 | 1998 | 4 | 0.140 |
Why?
|
| Gastric Mucosa | 1 | 2021 | 487 | 0.130 |
Why?
|
| RNA, Double-Stranded | 8 | 1994 | 59 | 0.130 |
Why?
|
| Metals | 1 | 2018 | 57 | 0.130 |
Why?
|
| Animals, Newborn | 3 | 2003 | 1016 | 0.130 |
Why?
|
| Serotyping | 9 | 1993 | 172 | 0.130 |
Why?
|
| RNA, Messenger | 5 | 1996 | 2542 | 0.130 |
Why?
|
| Antibodies, Viral | 4 | 1998 | 1133 | 0.130 |
Why?
|
| Trypsin | 5 | 2001 | 81 | 0.130 |
Why?
|
| Consensus Sequence | 1 | 1996 | 53 | 0.130 |
Why?
|
| Kinetics | 9 | 1994 | 1092 | 0.130 |
Why?
|
| Bacteremia | 2 | 2017 | 420 | 0.120 |
Why?
|
| Mammalian orthoreovirus 3 | 5 | 1980 | 6 | 0.120 |
Why?
|
| Gene Expression Regulation, Viral | 1 | 1996 | 122 | 0.120 |
Why?
|
| Viral Structural Proteins | 3 | 1998 | 39 | 0.120 |
Why?
|
| Antibiosis | 1 | 2015 | 14 | 0.120 |
Why?
|
| Urinary Catheters | 1 | 2015 | 26 | 0.110 |
Why?
|
| Biodiversity | 1 | 2015 | 73 | 0.110 |
Why?
|
| Animals, Suckling | 3 | 1991 | 51 | 0.110 |
Why?
|
| Virion | 5 | 1996 | 116 | 0.110 |
Why?
|
| Vaccination | 4 | 2007 | 1003 | 0.110 |
Why?
|
| Microbiota | 2 | 2021 | 427 | 0.110 |
Why?
|
| Viral Plaque Assay | 7 | 1993 | 42 | 0.110 |
Why?
|
| Mice | 14 | 2021 | 17699 | 0.110 |
Why?
|
| Crosses, Genetic | 8 | 1990 | 154 | 0.110 |
Why?
|
| Urinary Bladder | 1 | 2015 | 247 | 0.100 |
Why?
|
| Viral Core Proteins | 1 | 1993 | 17 | 0.100 |
Why?
|
| Cell Fusion | 1 | 1993 | 33 | 0.100 |
Why?
|
| Cattle Diseases | 1 | 1993 | 20 | 0.100 |
Why?
|
| Cattle | 7 | 2013 | 540 | 0.100 |
Why?
|
| Viral Vaccines | 6 | 1998 | 314 | 0.100 |
Why?
|
| Epitopes | 2 | 1992 | 421 | 0.100 |
Why?
|
| Heart-Assist Devices | 1 | 2021 | 1045 | 0.100 |
Why?
|
| Viral Fusion Proteins | 1 | 1993 | 73 | 0.100 |
Why?
|
| Diarrhea | 4 | 1991 | 305 | 0.090 |
Why?
|
| Chlorides | 1 | 1992 | 98 | 0.090 |
Why?
|
| Ceratopogonidae | 2 | 1989 | 2 | 0.090 |
Why?
|
| Sequence Analysis, DNA | 2 | 2011 | 1712 | 0.090 |
Why?
|
| Bluetongue | 2 | 1989 | 2 | 0.090 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2013 | 174 | 0.090 |
Why?
|
| Urinary Tract Infections | 1 | 2015 | 316 | 0.080 |
Why?
|
| Superinfection | 1 | 1990 | 7 | 0.080 |
Why?
|
| Disease Models, Animal | 6 | 2018 | 4449 | 0.080 |
Why?
|
| Species Specificity | 7 | 1989 | 516 | 0.080 |
Why?
|
| Neutralization Tests | 4 | 1993 | 225 | 0.080 |
Why?
|
| Phenotype | 10 | 2003 | 4309 | 0.080 |
Why?
|
| Immunity, Maternally-Acquired | 1 | 1989 | 35 | 0.080 |
Why?
|
| Microscopy, Electron | 5 | 2001 | 309 | 0.080 |
Why?
|
| Base Sequence | 4 | 2017 | 2763 | 0.070 |
Why?
|
| Haplorhini | 5 | 1998 | 107 | 0.070 |
Why?
|
| Heart Failure | 1 | 2021 | 2289 | 0.070 |
Why?
|
| Escherichia coli Infections | 2 | 2021 | 184 | 0.070 |
Why?
|
| Vero Cells | 4 | 1993 | 112 | 0.070 |
Why?
|
| Rotavirus Vaccines | 1 | 2007 | 60 | 0.060 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 5 | 1992 | 260 | 0.060 |
Why?
|
| Mice, Inbred BALB C | 2 | 2021 | 1000 | 0.060 |
Why?
|
| Antibody Specificity | 3 | 1993 | 199 | 0.060 |
Why?
|
| Spodoptera | 2 | 1996 | 28 | 0.060 |
Why?
|
| Protein Conformation | 3 | 2003 | 803 | 0.060 |
Why?
|
| Humans | 18 | 2021 | 127627 | 0.060 |
Why?
|
| Amino Acid Sequence | 4 | 2002 | 2544 | 0.050 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 337 | 0.050 |
Why?
|
| Genetic Markers | 2 | 1997 | 599 | 0.050 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 3 | 1992 | 787 | 0.050 |
Why?
|
| Mammals | 1 | 2004 | 247 | 0.050 |
Why?
|
| Peptides | 4 | 1989 | 830 | 0.050 |
Why?
|
| Hydrogen-Ion Concentration | 2 | 1993 | 426 | 0.050 |
Why?
|
| Molecular Weight | 5 | 1994 | 298 | 0.040 |
Why?
|
| Cells, Cultured | 4 | 1994 | 2902 | 0.040 |
Why?
|
| Genetic Fitness | 1 | 2021 | 31 | 0.040 |
Why?
|
| Adaptation, Biological | 1 | 2021 | 32 | 0.040 |
Why?
|
| Specific Pathogen-Free Organisms | 1 | 2021 | 54 | 0.040 |
Why?
|
| Precipitin Tests | 2 | 1992 | 136 | 0.040 |
Why?
|
| Drug Antagonism | 1 | 2020 | 12 | 0.040 |
Why?
|
| Genotype | 4 | 1993 | 2600 | 0.040 |
Why?
|
| Germ-Free Life | 2 | 1993 | 61 | 0.040 |
Why?
|
| In Vitro Techniques | 3 | 1991 | 826 | 0.040 |
Why?
|
| Symbiosis | 1 | 2021 | 91 | 0.040 |
Why?
|
| Administration, Oral | 1 | 2002 | 687 | 0.040 |
Why?
|
| Drug Synergism | 1 | 2020 | 232 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2021 | 271 | 0.040 |
Why?
|
| Virulence Factors | 1 | 2021 | 170 | 0.040 |
Why?
|
| Genetic Complementation Test | 3 | 1983 | 86 | 0.040 |
Why?
|
| Macaca mulatta | 2 | 1998 | 481 | 0.040 |
Why?
|
| Vaccines, Attenuated | 3 | 1998 | 173 | 0.040 |
Why?
|
| Morphogenesis | 2 | 1993 | 192 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2002 | 533 | 0.040 |
Why?
|
| Bacterial Load | 1 | 2018 | 33 | 0.030 |
Why?
|
| Selection, Genetic | 2 | 1991 | 155 | 0.030 |
Why?
|
| Hemagglutinins, Viral | 2 | 1993 | 22 | 0.030 |
Why?
|
| Organoids | 1 | 2021 | 283 | 0.030 |
Why?
|
| Staphylococcus aureus | 1 | 2021 | 476 | 0.030 |
Why?
|
| Insect Vectors | 2 | 1989 | 106 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 1989 | 414 | 0.030 |
Why?
|
| Vaccines, Synthetic | 1 | 1998 | 316 | 0.030 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2020 | 825 | 0.030 |
Why?
|
| Bacterial Translocation | 1 | 2017 | 24 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1996 | 55 | 0.030 |
Why?
|
| Molecular Biology | 1 | 1997 | 68 | 0.030 |
Why?
|
| Guanosine Triphosphate | 1 | 1996 | 38 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 1996 | 299 | 0.030 |
Why?
|
| Biological Evolution | 1 | 1997 | 222 | 0.030 |
Why?
|
| Neutropenia | 1 | 2017 | 198 | 0.030 |
Why?
|
| Cryoelectron Microscopy | 1 | 2017 | 226 | 0.030 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1996 | 147 | 0.030 |
Why?
|
| Viral Interference | 3 | 1983 | 6 | 0.030 |
Why?
|
| Urine | 1 | 2015 | 93 | 0.030 |
Why?
|
| Immunocompromised Host | 1 | 2017 | 304 | 0.030 |
Why?
|
| Urinary Catheterization | 1 | 2015 | 80 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 2 | 1992 | 989 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 511 | 0.030 |
Why?
|
| Protein Processing, Post-Translational | 2 | 1994 | 348 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 150 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 382 | 0.030 |
Why?
|
| Chymotrypsin | 1 | 1993 | 14 | 0.030 |
Why?
|
| Cell-Free System | 1 | 1993 | 62 | 0.030 |
Why?
|
| Hemagglutination Tests | 1 | 2013 | 9 | 0.030 |
Why?
|
| Alkalies | 1 | 1993 | 24 | 0.030 |
Why?
|
| Cloning, Molecular | 2 | 1985 | 784 | 0.030 |
Why?
|
| Dactinomycin | 1 | 1993 | 48 | 0.030 |
Why?
|
| N-Acetylneuraminic Acid | 1 | 2013 | 23 | 0.030 |
Why?
|
| Immune Sera | 1 | 1993 | 84 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 680 | 0.030 |
Why?
|
| Virus Attachment | 1 | 2013 | 32 | 0.020 |
Why?
|
| Cricetulus | 1 | 2013 | 87 | 0.020 |
Why?
|
| CHO Cells | 1 | 2013 | 148 | 0.020 |
Why?
|
| Chickens | 1 | 1993 | 285 | 0.020 |
Why?
|
| Cricetinae | 1 | 2013 | 365 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 1296 | 0.020 |
Why?
|
| Virulence | 1 | 1993 | 270 | 0.020 |
Why?
|
| Cesium | 1 | 1992 | 7 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1992 | 54 | 0.020 |
Why?
|
| Hybridomas | 1 | 1992 | 38 | 0.020 |
Why?
|
| Female | 5 | 2021 | 68835 | 0.020 |
Why?
|
| Immunoblotting | 1 | 1992 | 292 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2013 | 720 | 0.020 |
Why?
|
| Cross Reactions | 1 | 1992 | 181 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 6266 | 0.020 |
Why?
|
| Feces | 2 | 1998 | 702 | 0.020 |
Why?
|
| Kidney | 2 | 1993 | 1284 | 0.020 |
Why?
|
| Hemolytic Plaque Technique | 1 | 1987 | 4 | 0.020 |
Why?
|
| Ileum | 1 | 1988 | 123 | 0.020 |
Why?
|
| Rabbits | 2 | 1998 | 628 | 0.020 |
Why?
|
| Sheep | 1 | 1987 | 224 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 1987 | 786 | 0.010 |
Why?
|
| Stomach | 1 | 1988 | 267 | 0.010 |
Why?
|
| Membrane Proteins | 1 | 1993 | 1569 | 0.010 |
Why?
|
| Phosphorus Radioisotopes | 1 | 1985 | 13 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1986 | 291 | 0.010 |
Why?
|
| Culture Media | 1 | 1985 | 173 | 0.010 |
Why?
|
| Male | 3 | 2021 | 62967 | 0.010 |
Why?
|
| Guinea Pigs | 1 | 1984 | 157 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2015 | 6719 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 1989 | 2240 | 0.010 |
Why?
|
| Hot Temperature | 1 | 1984 | 138 | 0.010 |
Why?
|
| Retrospective Studies | 1 | 2021 | 17111 | 0.010 |
Why?
|
| Ultracentrifugation | 1 | 2002 | 21 | 0.010 |
Why?
|
| Protein Structure, Quaternary | 1 | 2002 | 94 | 0.010 |
Why?
|
| Age Factors | 1 | 1988 | 2816 | 0.010 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 1990 | 967 | 0.010 |
Why?
|
| Glycoproteins | 1 | 1982 | 338 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2013 | 8391 | 0.010 |
Why?
|
| Models, Molecular | 1 | 2003 | 1059 | 0.010 |
Why?
|
| Liver Neoplasms | 1 | 1990 | 1350 | 0.010 |
Why?
|
| Genetic Variation | 2 | 1983 | 1509 | 0.010 |
Why?
|
| Aluminum Compounds | 1 | 1998 | 16 | 0.010 |
Why?
|
| Saponins | 1 | 1998 | 21 | 0.010 |
Why?
|
| Freund's Adjuvant | 1 | 1998 | 25 | 0.010 |
Why?
|
| Injections, Intramuscular | 1 | 1998 | 182 | 0.010 |
Why?
|
| Phosphates | 1 | 1998 | 108 | 0.010 |
Why?
|
| Virus Shedding | 1 | 1998 | 75 | 0.010 |
Why?
|
| Immunoglobulin A | 1 | 1998 | 205 | 0.010 |
Why?
|
| Disease Transmission, Infectious | 1 | 1998 | 75 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 20525 | 0.010 |
Why?
|
| Pregnancy | 1 | 1989 | 7426 | 0.010 |
Why?
|
| Nucleic Acid Conformation | 1 | 1977 | 169 | 0.010 |
Why?
|
| Adjuvants, Immunologic | 1 | 1998 | 380 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 1998 | 794 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 27900 | 0.010 |
Why?
|
| Myristic Acid | 1 | 1994 | 5 | 0.010 |
Why?
|
| Myristic Acids | 1 | 1994 | 6 | 0.010 |
Why?
|
| Inclusion Bodies, Viral | 1 | 1994 | 10 | 0.010 |
Why?
|
| Sequence Analysis | 1 | 1994 | 51 | 0.010 |
Why?
|
| Desiccation | 1 | 1994 | 43 | 0.010 |
Why?
|
| Osmolar Concentration | 1 | 1994 | 148 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1994 | 237 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1994 | 435 | 0.010 |
Why?
|
| Models, Structural | 1 | 1993 | 43 | 0.010 |
Why?
|
| Freezing | 1 | 1993 | 24 | 0.010 |
Why?
|
| Computer Graphics | 1 | 1993 | 37 | 0.010 |
Why?
|
| Macromolecular Substances | 1 | 1993 | 141 | 0.010 |
Why?
|
| Methionine | 1 | 1993 | 90 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1993 | 114 | 0.010 |
Why?
|
| Protein Binding | 1 | 1994 | 1665 | 0.010 |
Why?
|
| Genetic Code | 2 | 1978 | 22 | 0.000 |
Why?
|
| Cell Differentiation | 1 | 1991 | 1871 | 0.000 |
Why?
|
| Carbohydrate Sequence | 1 | 1982 | 18 | 0.000 |
Why?
|
| Protein Precursors | 1 | 1982 | 144 | 0.000 |
Why?
|
| Hemagglutination | 1 | 1978 | 7 | 0.000 |
Why?
|
| Tromethamine | 1 | 1978 | 7 | 0.000 |
Why?
|
| Acetates | 1 | 1978 | 81 | 0.000 |
Why?
|
| Erythrocytes | 1 | 1978 | 190 | 0.000 |
Why?
|
| Cytoplasm | 1 | 1978 | 251 | 0.000 |
Why?
|
| Glycine | 1 | 1978 | 162 | 0.000 |
Why?
|